Growth Metrics

Rapid Micro Biosystems (RPID) Gains from Investment Securities (2020 - 2025)

Rapid Micro Biosystems' Gains from Investment Securities history spans 6 years, with the latest figure at $8000.0 for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities changed N/A to $8000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $30000.0, a N/A change, with the full-year FY2025 number at $30000.0, changed N/A from a year prior.
  • Gains from Investment Securities hit $8000.0 in Q4 2025 for Rapid Micro Biosystems, down from $22000.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for RPID hit a ceiling of $8.2 million in Q3 2021 and a floor of -$61000.0 in Q4 2023.
  • Historically, Gains from Investment Securities has averaged $1.1 million across 5 years, with a median of $8000.0 in 2024.
  • Biggest five-year swings in Gains from Investment Securities: skyrocketed 2850.0% in 2022 and later crashed 187.5% in 2025.
  • Tracing RPID's Gains from Investment Securities over 5 years: stood at -$14000.0 in 2021, then skyrocketed by 2850.0% to $385000.0 in 2022, then plummeted by 115.84% to -$61000.0 in 2023, then surged by 113.11% to $8000.0 in 2024, then changed by 0.0% to $8000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for RPID at $8000.0 in Q4 2025, $22000.0 in Q3 2025, and -$7000.0 in Q2 2025.